Annual Congress Vienna 2009

Saturday, 12.09.2009
Sunday, 13.09.2009
Monday, 14.09.2009
Tuesday, 15.09.2009
Wednesday, 16.09.2009

Citations should be made in the following way: Authors. Title. Eur Respir J 2009; 34: Suppl. 53, abstract number.

Material from 2009:

4047 Abstracts
652 Slide presentations
300 Webcasts
93 Handouts
2150 e-posters
300 Multimedia files

Material from 2009: Show

Management of thoracic malignancies

Thematic Poster Session
Chairs: F. Gamarra (Munich, Germany), N. Triller (Golnik, Slovenia)

Download all media

The role of serum adhesion molecules and vascular endothelial growth factor in the treatment approach of the lung cancer patients A. S. Yurdakul, E. R. Han, N. Bukan, C. Öztürk (Ankara, Turkey)
The role of somatostatin analogues in combination to antineoplastic agents in the treatment of SCLC patients (preliminary findings) E. Eleftheriadou, G. Gerasimou, P. Zarogoulidis, C. Gioka, G. Balassoulis, I. Sapardanis, T. Kontakiotis, A. Gotzamani-Psarrakou, N. Karatzas, K. Zarogoulidis (Exohi, Thessaloniki, Thessaloniki, Greece)
Effectiveness of chemotherapy for advanced lung cancer in the elderly M. Petrovic, N. Ilic, I. Cekerevac, G. Kostic, L. Novkocic (Kragujevac, Republic Of Serbia)
Phase II study of gemcitabine plus irinotecan as second-line chemotherapy in advanced non-small cell lung cancer J. Y. Jung, M. K. Byun, J. A. Moon, J. E. Lim, E. Y. Kim, J. Y. Son, B. H. Park, J. W. Moon, M. S. Park, J. Chang, S. M. Kwak, S. K. Kim (Seoul, Incheon, Republic Of Korea)
Occult N2 disease after surgical resection for clinical stage I NSCLC: factors affecting survival J. Guarize, F. Braga, P. Mainsoneuve, F. Blasi, L. Spaggiari (Milan, Italy)
Impact of diabetes mellitus (dm) or hypertension and ischaemic heart disease (hd) on cisplatin nephrtotoxicity C. Mathe, A. Bohacs, L. Duffek, P. Magyar, G. Losonczy (Budapest, Hungary)
Survival after induction chemotherapy and surgery in N2 (mediastinoscopy) NSCLC patients J. Guarize, F. Braga, F. Blasi, L. Spaggiari (Milan, Italy)
Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis N. Giaj Levra, L. Todisco, C. Iftode, A. Botticella, P. Ciammella, C. Mantovani, A. R. Filippi, A. Guarneri, R. Ragona, U. Ricardi (Turin, Italy)
Respiratory symptoms and palliative care needs in lung cancer patients R. Milroy, D. Buchanan, A. Thompson, P. Levack (Glasgow, Dundee, United Kingdom)
Uncoupling of tumour blood flow and metabolism with increasing size; measurements using integrated dynamic CT and ¹⁸F-FDG-PET in non-small cell lung cancer T. Win, M. Shastry, K. Miles, S. Janes, R. Endozo, I. Kayani, L. Menezes, P. Ell, A. Groves (Stevenage, London, Brighton, United Kingdom)
Quality of life in patients with advanced NSCLC submited to chemotherapy S. Cini, L. Tavanti, F. Novelli, A. Chella, A. Palla (pisa, Italy)
Comparing cost of different drugs protocols in treatment lung cancer in Iran, 2005 (in Masih Daneshvari hospital) H. Zare, M. Azadi, H. Khodadad (Tehran, Islamic Republic Of Iran)
A preliminary study comparing pemetrexed/carboplatin (PC) versus docetaxel/carboplatin (DC) as second line therapy in lung cancer patients E. Eleftheriadou, P. Zarogoulidis, G. Balassoulis, E. Boutsikou, C. Gioka, I. Sapardanis, T. Tsiouda, T. Kontakiotis, K. Zarogoulidis (Exohi, Thessaloniki, Greece)
Prognosis of primary carcinoid tumors of the lung. A population based study A. Naalsund, H. Rostad, E. Heyerdahl Strøm, T. E. Strand (Oslo, Norway)
Pre-PET CT FNA in the evaluation of solitary pulmonary nodules reduces the benign surgical resection rate in an area of high granulomatous disease incidence J. Evans, Y. E. Ong, S. Grubnic, J. E. Seet, N. Walters, F. Chua, A. Draper (London, United Kingdom)
18 F-FDG PET/CT findings mimicking malignant disease in patients with pneumoconiosis (due to 4 cases) A. S. Yurdakul, A. Varol, S. Y. Akten, C. Öztürk (Ankara, Turkey)
Scintigraphic parameters in differential diagnostics of community acquired pneumonia and lung cancer Y. Lishmanov, N. Krivonogov, N. Dem‘Yanenko, T. Ageeva, A. Dubodelova, E. Mishustina, S. Mishustin, S. Avdeev, A. Zav‘yalov, E. Dubodelov (Tomsk, Russian Federation)
Comparision of FDG PET/CT and bone scanning for bone metastases in operable non-small cell lung cancer E. Canel Karakas, F. Kosar, S. Yurt, N. Isik, H. Ozcelik (Istanbul, Turkey)
Lung cancer occurrence in never smokers A. Zetos, D. Bisirtzoglou, K. Pagratis, E. Kainis, V. Kapordelis, G. Zarbis, G. Politis (Athens, Greece)
Reading numbers loudly – evaluation of breathlessness at rest in Polish patients with cancer I. Damps-Konstanska, M. Krajnik, B. Wajda, A. Modlinska, P. Krakowiak, E. Jassem (Gdansk, Bydgoszcz, Poland)